Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of Season
Clinical trial NCT01007721 · COMPLETED
Trial details
- NCT number
- NCT01007721
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-04-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.